This registry study is national, multi-center, prospective study without any interventions to the treatment strategies and/or decisions of the investigators. It is designed in order to determine the general profile of HCC patients in Turkey. Socio-demographic characteristics, family history, medical history and treatment pattern of HCC patients will be evaluated.
Study Type
OBSERVATIONAL
Enrollment
600
All treatment options (inc. surgery, TACE, drugs) will be registered.
Unnamed facility
Multiple Locations, Turkey (Türkiye)
Descriptive analysis of HCC risk factors
i.e. smoking and alcohol consumption status; family history for hepatitis, HCC, and other malignancies; history of hepatic disease and blood transfusion; concomitant diseases; treatments applied
Time frame: Baseline
Descriptive analysis of clinical profile of newly diagnosed HCC patients
Time frame: Baseline
Number of participants with underlying liver disease and family history
Time frame: Baseline
Treatment options as applied by doctors to HCC patients
Time frame: Up to approximately 5 years
Overall survival time since diagnosis
Time frame: Up to approximately 5 years
Number of participants with adverse events
Time frame: Up to approximately 5 years
Descriptive analysis of demographic characteristics of HCC patients
Time frame: Baseline
Descriptive analysis of clinical characteristics of HCC patients
Time frame: Up to approximately 5 years
Descriptive analysis of tumor properties
Time frame: Up to approximately 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.